Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience, Regeneron Genetics Center Codevelop NGS Genotyping Panel for Population Sequencing

NEW YORK – Twist Bioscience and Regeneron Pharmaceuticals subsidiary Regeneron Genetics Center said on Monday that they have collaborated to develop a custom next-generation sequencing genotyping assay for population genetics.

Under the agreement, Twist will market the Diversity SNP Panel and make it available to customers worldwide.

Financial and other terms of the agreement were not disclosed.

Regeneron began using the custom NGS SNP panel in late 2020, John Overton, VP and chief sequencing officer, said in a statement. The panel includes approximately 1.4 million SNPs from a globally representative population.

In January, Twist revealed it is helping Regeneron convert from SNP microarrays to NGS-based genotyping with Twist's hybridization-based target capture panels. Twist has done at least $9 million in business with the pharma company.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.